Literature DB >> 7623842

B-cell-specific DNA binding by an E47 homodimer.

C P Shen1, T Kadesch.   

Abstract

B cells express a unique E-box-binding activity that contains basic helix-loop-helix (bHLH) proteins encoded by the E2A gene. E2A proteins play a central role in immunoglobulin gene transcription and are also required for the generation of the B-lymphocyte lineage. In muscle, E2A proteins bind DNA as heterodimers with muscle-specific bHLH partners, such as MyoD and myogenin, and these heterodimers are thought to be both necessary and sufficient for muscle determination in cultured cells. Our results indicate that in B cells, the bHLH partners for E2A proteins are not B-cell-restricted proteins, but are the E2A proteins themselves. UV cross-linking, gel purification, and the analysis of "forced heterodimers" indicate that BCF1 is primarily a homodimer of the E2A protein E47. Since E47 is widely expressed, our results argue for a difference in the inherent DNA-binding properties of the E47 protein in B cells and may help explain the restricted B-lineage defect observed in E2A-deficient mice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7623842      PMCID: PMC230691          DOI: 10.1128/MCB.15.8.4518

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  28 in total

1.  Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo.

Authors:  A B Lassar; R L Davis; W E Wright; T Kadesch; C Murre; A Voronova; D Baltimore; H Weintraub
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

2.  B-cell- and myocyte-specific E2-box-binding factors contain E12/E47-like subunits.

Authors:  C Murre; A Voronova; D Baltimore
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

3.  The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials.

Authors:  M P Kamps; A T Look; D Baltimore
Journal:  Genes Dev       Date:  1991-03       Impact factor: 11.361

4.  Tissue-specific gene activation by MyoD: determination of specificity by cis-acting repression elements.

Authors:  H Weintraub; T Genetta; T Kadesch
Journal:  Genes Dev       Date:  1994-09-15       Impact factor: 11.361

5.  An intermolecular disulfide bond stabilizes E2A homodimers and is required for DNA binding at physiological temperatures.

Authors:  R Benezra
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

6.  The helix-loop-helix gene E2A is required for B cell formation.

Authors:  Y Zhuang; P Soriano; H Weintraub
Journal:  Cell       Date:  1994-12-02       Impact factor: 41.582

7.  Patterns of Pan expression and role of Pan proteins in endocrine cell type-specific complex formation.

Authors:  C A Vierra; Y Jacobs; L Ly; C Nelson
Journal:  Mol Endocrinol       Date:  1994-02

8.  Distribution and characterization of helix-loop-helix enhancer-binding proteins from pancreatic beta cells and lymphocytes.

Authors:  A Aronheim; H Ohlsson; C W Park; T Edlund; M D Walker
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

9.  MyoD or Myf-5 is required for the formation of skeletal muscle.

Authors:  M A Rudnicki; P N Schnegelsberg; R H Stead; T Braun; H H Arnold; R Jaenisch
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

10.  E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements.

Authors:  G Bain; E C Maandag; D J Izon; D Amsen; A M Kruisbeek; B C Weintraub; I Krop; M S Schlissel; A J Feeney; M van Roon
Journal:  Cell       Date:  1994-12-02       Impact factor: 41.582

View more
  61 in total

1.  Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene.

Authors:  L Pan; S Sato; J P Frederick; X H Sun; Y Zhuang
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 2.  Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms.

Authors:  M E Massari; C Murre
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Lactation defect in mice lacking the helix-loop-helix inhibitor Id2.

Authors:  S Mori; S I Nishikawa; Y Yokota
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

4.  Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development.

Authors:  Toni Portis; Richard Longnecker
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  A network of broadly expressed HLH genes regulates tissue-specific cell fates.

Authors:  Abhishek Bhattacharya; Nicholas E Baker
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

6.  Identification of cyclin D3 as a direct target of E2A using DamID.

Authors:  Siyuan Song; Jonathan Cooperman; Danielle L Letting; Gerd A Blobel; John Kim Choi
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

7.  E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription.

Authors:  Frederic Lluís; Esteban Ballestar; Mònica Suelves; Manel Esteller; Pura Muñoz-Cánoves
Journal:  EMBO J       Date:  2005-02-17       Impact factor: 11.598

8.  Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation.

Authors:  S E Johnson; X Wang; S Hardy; E J Taparowsky; S F Konieczny
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

9.  Mechanism of e47-Pip interaction on DNA resulting in transcriptional synergy and activation of immunoglobulin germ line sterile transcripts.

Authors:  Sujatha Nagulapalli; Aisha Goheer; Leslie Pitt; Lawrence P McIntosh; Michael L Atchison
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

10.  NeuroD2 and neuroD3: distinct expression patterns and transcriptional activation potentials within the neuroD gene family.

Authors:  M B McCormick; R M Tamimi; L Snider; A Asakura; D Bergstrom; S J Tapscott
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.